Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: A review

Neurosurgery

Volumn 47, Issue 4, 2000, Pages 888-901

  Taylor, Michael D ^a   Mainprize, Todd G ^a   Rutka, James T ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Familial tumor syndrome; Gorlin syndrome; Li Fraumeni syndrome; Medulloblastoma; PNET; Primitive neuroectodermal tumor; Turcot syndrome

Indexed keywords

PROTEIN P53; SONIC HEDGEHOG PROTEIN;

ANIMAL TISSUE; BASAL CELL NEVUS SYNDROME; CARCINOGENESIS; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; FAMILIAL CANCER; FAMILIAL DISEASE; GENE MUTATION; GENETIC DISORDER; HUMAN; INCIDENCE; MEDULLOBLASTOMA; MOUSE; NEUROECTODERM TUMOR; NONHUMAN; PRIORITY JOURNAL; REVIEW; RUBINSTEIN SYNDROME; TURCOT SYNDROME;

EID: 0034493199     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-200010000-00020     Document Type: Review

References (204)

1. p53 Gene mutation and mdm2 gene amplification are uncommon in medulloblastoma
2. Drosophila CBP is a coactivator of cubitus interruptus in hedgehog signaling
3. Rubinstein-Taybi syndrome: Objective evaluation of craniofacial structure
4. An insight into the life of p53: A protein coping with many functions! Review of the 9th p53 Workshop, Crete, May 9-13, 1998
5. Trilateral retinoblastoma: A report of five patients
6. Bilateral retinoblastoma with ectopic intracranial retinoblastoma: Trilateral retinoblastoma
7. Trilateral retinoblastoma
8. N-myc and c-myc oncogenes amplification in medulloblastomas: Evidence of particularly aggressive behavior of a tumor with c-myc amplification
9. Imaging in the trilateral retinoblastoma syndrome
10. A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family
11. Multiple roles of cholesterol in hedgehog protein biogenesis and signaling
12. Association of a suprasellar mass and intraocular retinoblastoma: A variant of pineal trilateral retinoblastoma?
13. Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly
14. Cytogenetics and molecular genetics of childhood brain tumors
15. Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor
16. Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain
17. Monosomy 22 in rhabdoid or atypical tumors of the brain
18. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors
19. Amplification and over-expression of MDM2 in primary (de novo) glioblastomas
20. Strike three for GLI3
21. Pallister-Hall syndrome
22. Familial Pallister-Hall syndrome
23. Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma
24. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts
25. Trilateral retinoblastoma: Incidence and outcome - A decade of experience
26. The p53 gene and its role in human brain tumors
27. Retinoblastoma protein recruits histone deacetylase to repress transcription
28. Expression of the c-Myc protein in childhood medulloblastoma
29. The Coffin-Siris syndrome: Five new cases including two siblings
30. Characterization of two patched receptors for the vertebrate hedgehog protein family
31. Genetic origin of mutations predisposing to retinoblastoma
32. Cultured diploid fibroblasts from patients with the nevoid basal cell carcinoma syndrome are hypersensitive to killing by ionizing radiation
33. Identical twins with medulloblastoma occurring in infancy
34. Gene amplification in human gliomas
35. Teratogen-mediated inhibition of target tissue response to Shh signaling
36. Sonic Hedgehog-induced activation of the Gli1 promoter is mediated by GLI3
37. Evidence for a mitogenic effect of Wnt-1 in the developing mammalian central nervous system
38. A new germline TP53 gene mutation in a family with Li-Fraumeni syndrome
39. The trilateral retinoblastoma syndrome
40. Identification of germline and somatic mutations affecting the retinoblastoma gene
41. Nuclear localization and mutation of beta-catenin in medulloblastomas
42. Mortality from second tumors among long-term survivors of retinoblastoma
43. Antagonizing cAMP-dependent protein kinase A in the dorsal CNS activates a conserved Sonic hedgehog signaling pathway
44. Congenital anomalies and genetic syndromes in 173 cases of medulloblastoma
45. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma
46. Location of gene for Gorlin syndrome
47. Trilateral retinoblastoma: Two variations
48. A tale of four syndromes: Familial adenomatous polyposis, Gardner syndrome, attenuated APC and Turcot syndrome
49. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome
50. Functions of the MDM2 oncoprotein
51. Amplified cellular oncogenes in neoplasms of the human central nervous system
52. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9
53. The complexity of p53 modulation: Emerging patterns from divergent signals
54. Conjunction dysfunction: CBP/p300 in human disease
55. Second cancers after medulloblastoma: Population-based results from the United States and Sweden
56. Hedgehog and patched in neural development and disease
57. Altered neural cell fates and medulloblastoma in mouse patched mutants
58. Nevoid basal-cell carcinoma syndrome
59. Nevoid basal cell carcinoma syndrome
60. A cluster of Pallister-Hall syndrome cases (congenital hypothalamic hamartoblastoma syndrome)
61. Autosomal dominant inheritance of hypothalamic hamartoma associated with polysyndactyly: Heterogeneity or variable expressivity?
62. Colon-cancer genes and brain tumors
63. Carcinogenesis: A balance between beta-catenin and APC
64. Propagation and localization of Wnt signaling
65. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome
66. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome
67. The molecular basis of Turcot's syndrome
68. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell
69. Down-regulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta
70. Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia
71. Identification of c-MYC as a target of the APC pathway
72. The retinoblastoma gene is involved in malignant progression of astrocytomas
73. p53 Gene mutation in cerebral primitive neuroectodermal tumor in Taiwan
74. APC mutations in sporadic medulloblastomas
75. Familial medulloblastoma in siblings: Report in one family and review of the literature
76. Control of cell pattern in the neural tube by the zinc finger transcription factor and oncogene Gli-1
77. The patched gene in development and cancer
78. Transducing hedgehog: The story so far
79. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations
80. Human homolog of patched, a candidate gene for the basal cell nevus syndrome
81. Over-expression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
82. Congenital anomalies and genetic disorders in families of children with central nervous system tumours
83. Neurologic and other disorders in relatives of pediatric patients with CNS tumors
84. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome
85. Can p53 status resolve paradoxes between human and non-human retinoblastoma models?
86. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome
87. The GLI gene encodes a nuclear protein which binds specific sequences in the human genome
88. Identification of an amplified, highly expressed gene in a human glioma
89. The GLI gene is a member of the Kruppel family of zinc finger proteins
90. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin
91. Mutation and cancer: Statistical study of retinoblastoma
92. -/- colon carcinoma
93. Brain tumors in familial adenomatous polyposis
94. Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals
95. A frequent activated smoothened mutation in sporadic basal cell carcinomas
96. The human F box protein beta-Trcp associates with the Cull/Skp1 complex and regulates the stability of beta-catenin
97. Analysis of DNA mismatch repair proteins in human medulloblastoma
98. Rhabdomyosarcoma in children: Epidemiologic study and identification of a familial cancer syndrome
99. Binding and modulation of p53 by p300/CBP coactivators
100. Beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation
101. Elevated c-myc expression in childhood medulloblastomas
102. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
103. Trilateral retinoblastoma: Insights into histogenesis and management
104. Primitive neuroectodermal tumor of the midbrain in a murine model of retinoblastoma
105. Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen
106. Beta-TrCP is a negative regulator of Wnt/beta-catenin signaling pathway and dorsal axis formation in Xenopus embryos
107. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum
108. Medulloblastoma and glioblastoma multiforme in a patient with Turcot syndrome: A case report
109. Tumors in Rubinstein-Taybi syndrome
110. Astrocytoma linked to familial ataxia-telangiectasia
111. Second primary tumors in patients with retinoblastoma: A review of the literature
112. Germ-line and somatic mutations of the APC gene in patients with Turcot syndrome and analysis of APC mutations in brain tumors
113. Familial medulloblastoma
114. A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm
115. Malignant ependymomas in a patient with Turcot's syndrome: Case report and management guidelines
116. Sonic hedgehog signaling by the patched-smoothened receptor complex
117. Analysis of APCL, a brain-specific adenomatous polyposis coli homologue, for mutations and expression in brain tumors
118. Identification of a brainspecific APC homologue, APCL, and its interaction with beta-catenin
119. Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumors of the central nervous system: Reappraisal by yeast functional assay
120. Trilateral retinoblastoma: CT evaluation
121. Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: Implications for a dominant-negative mechanism
122. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis
123. Multiple neoplasms following craniospinal irradiation for medulloblastoma in a patient with nevoid basal cell carcinoma syndrome: Case report
124. Probable Opitz trigonocephaly C syndrome with medulloblastoma
125. A novel TP53 germ-line mutation identified in a girl with a primitive neuroectodermal tumor and her father
126. Basal cell carcinomas in mice overexpressing sonic hedgehog
127. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation
128. Brain tumor-polyposis syndrome: Two genetic diseases?
129. Trilateral retinoblastoma: Is the location of the intracranial tumor important?
130. Two families with the Li-Fraumeni cancer family syndrome
131. Beta-catenin as oncogene: The smoking gun
132. Triple autosomal trisomy in a pregnancy at risk for Bloom's syndrome
133. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
134. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched
135. Mdm2: Keeping p53 under control
136. The adenomatous polyposis coli (APC) tumor suppressor
137. The oncogenic activation of beta-catenin
138. Hedgehog patterning activity: Role of a lipophilic modification mediated by the carboxy-terminal autoprocessing domain
139. The product of hedgehog autoproteolytic cleavage active in local and long-range signaling
140. Cholesterol modification of hedgehog signaling proteins in animal development
141. Sporadic medulloblastomas contain PTCH mutations
142. Absence of p53 mutations in childhood central nervous system primitive neuroectodermal tumors
143. Genetic alterations in glioma and medulloblastoma
144. Amplification and over-expression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations
145. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system
146. Mutations in the human Sonic hedgehog gene cause holoprosencephaly
147. Mutations in the C-terminal domain of Sonic hedgehog cause holoprosencephaly
148. Medulloblastoma in association with the Coffin-Siris syndrome
149. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood
150. Stabilization of beta-catenin by genetic defects in melanoma cell lines
151. The GLI-Kruppel family of human genes
152. GLI3 encodes a 190-kD protein with multiple regions of GLI similarity
153. The zinc finger protein GLI transforms primary cells in cooperation with adenovirus E1A
154. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
155. Molecular genetic analysis of the Gli1 gene for mutation in basal cell carcinoma of the skin and primitive neuroectodermal tumors of the central nervous system
156. Molecular analysis of medulloblastomas occurring simultaneously in monozygotic twins
157. Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas
158. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations
159. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway
160. Medulloblastoma in patient with Rubinstein-Taybi syndrome
161. Trilateral retinoblastoma with suprasellar involvement
162. Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene in basal cell carcinoma and medulloblastoma on chromosome 1p32
163. Trilateral retinoblastoma: A case report
164. Germline transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome
165. Trilateral retinoblastoma
166. The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog
167. One-eyed animals implicate cholesterol in development
168. A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals
169. Abnormal skeletal patterning in embryos lacking a single Cbp allele: A partial similarity with Rubinstein-Taybi syndrome
170. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene
171. A familial reciprocal translocation t(3;7) (p21.1;p13) associated with the Greig polysyndactylycraniofacial anomalies syndrome
172. Multiple ependymomas in a patient with Turcot's syndrome
173. The Coffin-Siris syndrome
174. Concepts regarding polyposis of the colon
175. Nijmegen breakage syndrome
176. Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor
177. "Turcot's syndrome": Phenotype of brain tumors, survival and mode of inheritance
178. Li-Fraumeni syndrome: A molecular and clinical review
179. Germ-line mutations of TP53 in Li-Fraumeni families: An extended study of 39 families
180. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
181. Evidence for the involvement of the Wnt 2 gene in human colorectal cancer
182. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours
183. Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma
184. Purkinje-cell-derived Sonic hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum
185. Drosophila CBP represses the transcription factor TCF to antagonize Wingless signaling
186. Oncogene amplification in pediatric brain tumors
187. Control of neuronal precursor proliferation in the cerebellum by Sonic hedgehog
188. The retinoblastoma protein and cell cycle control
189. Accelerated central nervous system tumorigenesis in mice with both Patched and p53 genes
190. No evidence for the H133Y mutation in Sonic hedgehog in a collection of common tumour types
191. Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the Patched protein, and no genotype-phenotype correlations are evident
192. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro
193. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system
194. Mapping of Beta-TRCP, a human homolog of the Drosophila slimb gene, to chromosome band 10q24 and mutational analysis of basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system
195. Mutations of the Patched gene in several types of sporadic extra-cutaneous tumors
196. Activating smoothened mutations in sporadic basal-cell carcinoma
197. A frizzled homolog functions in a vertebrate Wnt signaling pathway
198. The APC gene in Turcot's syndrome
199. PTCH2, a novel human patched gene, undergoing alternative splicing and up-regulated in basal cell carcinomas
200. Trilateral retinoblastoma
201. Trilateral retinoblastoma: Ectopic intracranial retinoblastoma associated with bilateral retinoblastoma
202. Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma
203. Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice
204. Sporadic medulloblastomas contain oncogenic beta-catenin mutations